Data search
Results for MligTC455_34316
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_34316 | 68 | 1.42 | Mlig455_062660 | Neo: - Age: - |
Mlig455_062660 {REF} {Length: 1710} {TRANSSPLICED} {RNA1509_48329} {RNA1310_18117} {RNA815_28436} |
Cumulative graph for MligTC455_34316
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.047 | 1.61 | 0.85364 | 1.00000 | |
| RegionR2 | 1.869 | 1.61 | 0.11142 | 0.41257 | |
| RegionR3 | 1.73 | 1.61 | 0.07258 | 0.47790 | |
| RegionR4 | -0.158 | 1.61 | 0.84071 | 1.00000 | |
| RegionR5 | -0.916 | 1.61 | 0.98146 | 1.00000 | |
| RegionR6 | 1.051 | 1.61 | 0.32160 | 0.91078 | |
| RegionR7 | -3.598 | 1.61 | 0.22064 | 0.84174 | |
| RegionR8 | -0.024 | 1.61 | 0.84949 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -3.664 | 1.61 | 0.60861 | 1.00000 | |
| RegenerationR2 | 0.364 | 1.61 | 0.62312 | 0.92413 | |
| RegenerationR3 | 0.834 | 1.61 | 0.35510 | 0.77340 | |
| RegenerationR4 | 1.197 | 1.61 | 0.23929 | 0.68838 | |
| RegenerationR5 | 0.386 | 1.61 | 0.71844 | 0.95885 | |
| RegenerationR6 | -0.761 | 1.61 | 0.50818 | 0.81190 | |
| RegenerationBL | 1.294 | 1.61 | 0.42126 | 0.78949 | |
| RegenerationTP | 3.74 | 1.61 | 0.04264 | 0.34273 |
Genes with expression patterns similar to MligTC455_34316
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_34316 | 68 | 1.42 | Mlig455_062660 | Neo: - Age: - |
5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_062660 {REF} {Length: 1710} {TRANSSPLICED} {RNA1509_48329} {RNA1310_18117} {RNA815_28436} | |
| 2. | MligTC455_34315 | 256 | 5.34 | Mlig455_061276, Mlig455_061312 | Neo: - Age: - |
2.728 | 0.909 | - | - | 0.830 | - | 0.989 | Mlig455_061276 {REF} {Length: 1989} {RNA1509_48329} {RNA1310_18117} {RNA815_28436} Mlig455_061312 {REF} {Length: 2156} {RNA1509_48329} {RNA1310_18117} {RNA815_28436} |
|
| 3. | MligTC455_04162 | 131 | 2.73 | Mlig455_028924 | Neo: - |
HMCN1 | 1.853 | - | - | 0.952 | 0.901 | - | - | Mlig455_028924 {REF} {Length: 3929} {Pfam: Immunoglobulin domain [PF13927.8, score=144.9]; Immunoglobulin I-set domain [PF07679.18, score=119.8]; Immunoglobulin domain [PF13895.8, score=113.4]; Immunoglobulin domain [PF00047.27, score=102.3]; Immunoglobulin V-set domain [PF07686.19, score=36.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=35.3]; Immunoglobulin C1-set domain [PF07654.17, score=23.3]; C17orf99 Ig domain [PF17736.3, score=20.9]; Immunoglobulin domain [PF18452.3, score=19.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=103, Expect=2e-21]; ENSG00000148357, HMCN2, hemicentin 2, [Score=100, Expect=8e-21]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=107, Expect=5e-23]; ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=103, Expect=7e-22]} {Dmel: FBgn0000547, ed, echinoid, [Score=147, Expect=2e-35]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=100, Expect=3e-21]} {Smed: dd_Smed_v6_13903_0_1, dd_Smed_v6_13903_0_1, [Score=162, Expect=2e-40]} {RNA1310_26618} {RNA815_41641} |
| 4. | MligTC455_41077 | 483 | 10.07 | Mlig455_031143, Mlig455_031151 | Neo: - |
SLC8A3 | 1.845 | - | - | 0.970 | 0.875 | - | - | Mlig455_031143 {REF} {Length: 4359} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=180.5]; Calx-beta domain [PF03160.16, score=179.5]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=92.3]} {Human: ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [RH, Score=952, Expect=0.0]; ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [RH, Score=932, Expect=0.0]} {Mouse: ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [RH, Score=945, Expect=0.0]; ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [RH, Score=936, Expect=0.0]; ENSMUSG00000030376, Slc8a2, solute carrier family 8 (sodium/calcium exchanger), member 2, [RH, Score=917, Expect=0.0]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [RH, Score=829, Expect=0.0]} {Celegans: WBGene00003567, ncx-2, Na/Ca eXchangers, [RH, Score=878, Expect=0.0]} {Smed: dd_Smed_v6_3303_0_1, dd_Smed_v6_3303_0_1, [RH, Score=997, Expect=0.0]} {RNA1509_12866} {RNA1310_2685.1} {RNA815_13452} Mlig455_031151 {REF} {Length: 5266} {Pfam: Sodium/calcium exchanger protein [PF01699.26, score=179.9]; Calx-beta domain [PF03160.16, score=164.6]; C-terminal extension of sodium/calcium exchanger domain [PF16494.7, score=91.7]} {Human: ENSG00000100678, SLC8A3, solute carrier family 8 member A3, [Score=523, Expect=1e-169]; ENSG00000183023, SLC8A1, solute carrier family 8 member A1, [Score=498, Expect=7e-160]} {Mouse: ENSMUSG00000079055, Slc8a3, solute carrier family 8 (sodium/calcium exchanger), member 3, [Score=520, Expect=3e-168]; ENSMUSG00000054640, Slc8a1, solute carrier family 8 (sodium/calcium exchanger), member 1, [Score=503, Expect=7e-162]} {Dmel: FBgn0013995, Calx, Na/Ca-exchange protein, [Score=490, Expect=2e-160]} {Celegans: WBGene00003567, ncx-2, Na/Ca eXchangers, [Score=492, Expect=5e-158]} {Smed: dd_Smed_v6_3303_0_1, dd_Smed_v6_3303_0_1, [Score=549, Expect=4e-180]} {RNA1509_12866} {RNA1310_2685.2} {RNA815_13452} |
| 5. | MligTC455_41471 | 131 | 2.72 | Mlig455_040252, Mlig455_054698 | Neo: - Age: - Region-enriched R2: 3.576/0.00566 |
ANGPTL1 | 1.831 | - | - | 0.954 | 0.877 | - | - | Mlig455_040252 {REF} {Length: 2778} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=2e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=2e-26]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=1e-25]} {Dmel: FBgn0050280, CG30280, [Score=93.6, Expect=5e-22]} {Celegans: WBGene00020516, T15B7.1, [Score=61.6, Expect=1e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=9e-24]} {RNA1509_57196} {RNA1310_23214} {RNA815_19964} Mlig455_054698 {REF} {Length: 3143} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=108, Expect=4e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=105, Expect=6e-25]; ENSG00000160339, FCN2, ficolin 2, [Score=103, Expect=3e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=105, Expect=3e-25]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=105, Expect=4e-25]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=103, Expect=5e-25]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=103, Expect=2e-24]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=102, Expect=4e-25]; ENSMUSG00000015829, Tnr, tenascin R, [Score=102, Expect=7e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=9e-25]} {Dmel: FBgn0050280, CG30280, [Score=97.8, Expect=1e-23]} {Celegans: WBGene00020516, T15B7.1, [Score=62.0, Expect=9e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=2e-23]} {RNA1310_23214} {RNA815_19964} |
| 6. | MligTC455_46584 | 107 | 2.22 | Mlig455_010128 | Neo: - Age: Up-Down-Down |
KCNC2 | 1.829 | - | - | 0.965 | 0.864 | - | - | Mlig455_010128 {REF} {Length: 1706} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=74.3, Expect=3e-15]} {Mouse: ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=74.3, Expect=3e-16]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=114, Expect=3e-29]} {Celegans: WBGene00001202, egl-36, Potassium voltage-gated channel protein egl-36, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_17998_0_1, dd_Smed_v6_17998_0_1, [Score=118, Expect=1e-32]} {RNA1310_24374} {RNA815_11270} |
| 7. | MligTC455_27594 | 80 | 1.67 | Mlig455_026429 | Neo: - Age: - |
1.82 | - | - | 0.844 | - | - | 0.976 | Mlig455_026429 {REF} {Length: 3187} {Pfam: Otopetrin [PF03189.15, score=182.4]} {Dmel: FBgn0259150, CG42265, [Score=141, Expect=2e-34]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=92.4, Expect=4e-19]} {Smed: dd_Smed_v6_13612_0_1, dd_Smed_v6_13612_0_1, [Score=238, Expect=4e-69]} {RNA1509_24533} {RNA1310_4254.1} {RNA815_23661} | |
| 8. | MligTC455_37720 | 156 | 3.25 | Mlig455_027725, Mlig455_027921, Mlig455_027931 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.630/0.03113 |
TRPV6 | 1.818 | - | - | 0.968 | 0.850 | - | - | Mlig455_027725 {REF} {Length: 5690} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.6]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.7]; Polycystin cation channel [PF08016.14, score=27.5]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=4e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=1e-54]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=568, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=489, Expect=8e-156]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=492, Expect=6e-158]} {RNA1509_36869} {RNA1310_5278, RNA1509_36869} {RNA1509_36869, RNA815_5723} Mlig455_027921 {REF} {Length: 8298} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=39.2]; Ankyrin repeat [PF13606.8, score=33.0]; Ankyrin repeats (many copies) [PF13857.8, score=30.8]; Ankyrin repeat [PF00023.32, score=29.8]; Polycystin cation channel [PF08016.14, score=27.1]; Ankyrin repeats (many copies) [PF13637.8, score=21.3]} {Human: ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=4e-55]; ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=206, Expect=5e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=9e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=566, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=1e-155]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=491, Expect=1e-157]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} Mlig455_027931 {REF} {Length: 6147} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.7]; Ion transport protein [PF00520.33, score=40.0]; Ankyrin repeat [PF13606.8, score=34.3]; Ankyrin repeats (many copies) [PF13857.8, score=31.5]; Ankyrin repeat [PF00023.32, score=30.2]; Polycystin cation channel [PF08016.14, score=27.8]; Ankyrin repeats (many copies) [PF13637.8, score=21.7]} {Human: ENSG00000276971, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=208, Expect=7e-56]; ENSG00000165125, TRPV6, transient receptor potential cation channel subfamily V member 6, [RH, Score=207, Expect=1e-55]} {Mouse: ENSMUSG00000029868, Trpv6, transient receptor potential cation channel, subfamily V, member 6, [Score=206, Expect=3e-55]} {Dmel: FBgn0086693, iav, inactive, [RH, Score=567, Expect=0.0]} {Celegans: WBGene00003889, osm-9, Olfactory channel, [RH, Score=488, Expect=5e-157]} {Smed: dd_Smed_v6_28914_0_1, dd_Smed_v6_28914_0_1, [Score=490, Expect=4e-159]} {RNA1509_36869} {RNA1310_5278} {RNA815_5723} |
| 9. | MligTC455_33343 | 459 | 9.56 | Mlig455_063303 | Neo: - Age: - Region-enriched R2: 1.600/0.01675 |
ITPR1 | 1.811 | - | - | 0.950 | 0.861 | - | - | Mlig455_063303 {REF} {Length: 3962} {Pfam: RyR and IP3R Homology associated [PF08454.13, score=68.3]; Ion transport protein [PF00520.33, score=28.7]} {Human: ENSG00000150995, ITPR1, inositol 1,4,5-trisphosphate receptor type 1, [Score=166, Expect=6e-41]} {Mouse: ENSMUSG00000030102, Itpr1, inositol 1,4,5-trisphosphate receptor 1, [Score=182, Expect=7e-46]} {Dmel: FBgn0010051, Itp-r83A, Inositol 1,4,5,-tris-phosphate receptor, [Score=179, Expect=4e-45]} {Celegans: WBGene00002173, itr-1, Inositol 1,4,5-trisphosphate receptor itr-1, [Score=155, Expect=5e-38]} {Smed: dd_Smed_v6_3814_1_1, dd_Smed_v6_3814_1_1, [Score=1044, Expect=0.0]} {RNA1509_30811} {RNA1310_939} {RNA815_220} |
| 10. | MligTC455_19275 | 407 | 8.47 | Mlig455_037548 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 3.247/0.04164 |
CHRNA10 | 1.808 | - | - | 0.950 | 0.858 | - | - | Mlig455_037548 {REF} {Length: 959} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=96.7, Expect=1e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=97.1, Expect=7e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=95.1, Expect=5e-22]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=1e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=119, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=93.2, Expect=1e-21]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} |
| 11. | MligTC455_40878 | 355 | 7.39 | Mlig455_014130 | Neo: - Age: - |
1.768 | - | - | 0.954 | 0.814 | - | - | Mlig455_014130 {REF} {Length: 1465} {RNA1509_7458} {RNA1310_36212} {RNA815_1610.1} | |
| 12. | MligTC455_26473 | 1080 | 22.49 | Mlig455_023245 | Neo: - Age: Up-Down-Down Region-enriched R3: 5.994/0.00000 |
1.765 | - | - | 0.798 | - | - | 0.967 | Mlig455_023245 {REF} {Length: 5587} {Mouse: ENSMUSG00000006014, Prg4, proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein), [Score=59.7, Expect=2e-08]} {RNA1509_3202} {RNA1310_2753} {RNA815_1083.1} | |
| 13. | MligTC455_39860 | 56 | 1.17 | Mlig455_046932 | Neo: - Age: - |
1.752 | - | - | 0.964 | 0.788 | - | - | Mlig455_046932 {REF} {Length: 920} {RNA1310_30968} {RNA815_45889} | |
| 14. | MligTC455_41253 | 363 | 7.57 | Mlig455_035470 | Neo: - Age: Down-Up-Up |
1.737 | - | - | 0.782 | 0.955 | - | - | Mlig455_035470 {REF} {Length: 2010} {Pfam: Domain of unknown function (DUF4506) [PF14958.8, score=29.0]} {RNA1509_12597, RNA1509_26583} {RNA1310_15842, RNA1509_12597, RNA1509_26583} {RNA1509_12597, RNA1509_26583, RNA815_6253} | |
| 15. | MligTC455_38476 | 437 | 9.11 | Mlig455_006464 | Neo: - Age: logFC(26M/2M)=-0.343 |
ESPNL | 1.729 | - | - | - | 0.773 | 0.956 | - | Mlig455_006464 {REF} {Length: 3836} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=122.2]; Ankyrin repeats (many copies) [PF13637.8, score=89.0]; Ankyrin repeats (many copies) [PF13857.8, score=69.1]; Ankyrin repeat [PF13606.8, score=57.6]; Ankyrin repeat [PF00023.32, score=40.2]} {Human: ENSG00000144488, ESPNL, espin like, [RH, Score=131, Expect=4e-31]} {Mouse: ENSMUSG00000049515, Espnl, espin-like, [RH, Score=129, Expect=1e-30]; ENSMUSG00000028943, Espn, espin, [RH, Score=125, Expect=2e-29]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=85.9, Expect=7e-17]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=92.4, Expect=5e-19]} {Smed: dd_Smed_v6_14434_0_1, dd_Smed_v6_14434_0_1, [RH, Score=112, Expect=8e-26]} {RNA1509_15655} {RNA1310_12610} {RNA815_27159.1} |
| 16. | MligTC455_45538 | 379 | 7.89 | Mlig455_054128, Mlig455_060668 | Neo: - Age: logFC(26M/2M)=-0.316 |
NPR1, NPR2 | 1.712 | - | - | 0.955 | - | - | 0.757 | Mlig455_054128 {REF} {Length: 4761} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=226.8]; Receptor family ligand binding region [PF01094.30, score=163.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=132.0]; Protein kinase domain [PF00069.27, score=110.8]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=635, Expect=0.0]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=622, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=625, Expect=0.0]} {Dmel: FBgn0034568, CG3216, [RH, Score=693, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=839, Expect=0.0]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [RH, Score=964, Expect=0.0]} {RNA1509_8682} {RNA1310_3172} {RNA815_455} Mlig455_060668 {REF} {Length: 776} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=33.6]; Protein kinase domain [PF00069.27, score=23.5]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=105, Expect=6e-28]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=105, Expect=4e-28]} {Dmel: FBgn0051183, CG31183, [Score=90.1, Expect=1e-22]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=84.3, Expect=9e-21]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=106, Expect=1e-28]} {RNA1509_8682} {RNA1310_9433} {RNA815_455} |
| 17. | MligTC455_40882 | 435 | 9.07 | Mlig455_059173 | Neo: - Age: - |
GAD1 | 1.673 | - | - | 0.958 | 0.715 | - | - | Mlig455_059173 {REF} {Length: 3488} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=391.1]} {Human: ENSG00000128683, GAD1, glutamate decarboxylase 1, [RH, Score=659, Expect=0.0]} {Mouse: ENSMUSG00000070880, Gad1, glutamate decarboxylase 1, [RH, Score=659, Expect=0.0]} {Dmel: FBgn0004516, Gad1, Glutamic acid decarboxylase 1, [RH, Score=558, Expect=0.0]} {Celegans: WBGene00006762, unc-25, Glutamic acid decarboxylase, [RH, Score=595, Expect=0.0]} {Smed: dd_Smed_v6_12653_0_1, dd_Smed_v6_12653_0_1, [RH, Score=666, Expect=0.0]} {RNA1509_17310} {RNA1310_9376} {RNA815_16779} |
| 18. | MligTC455_30052 | 18 | 0.38 | Mlig455_034711 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.452/0.01054 |
1.667 | - | - | 0.953 | - | 0.714 | - | Mlig455_034711 {REF} {Length: 3673} {Smed: dd_Smed_v6_7411_0_1, dd_Smed_v6_7411_0_1, [RH, Score=48.9, Expect=2e-06]} {RNA1509_14295} {RNA1310_1396.1} {RNA815_549.1} | |
| 19. | MligTC455_28773 | 151 | 3.15 | Mlig455_014768, Mlig455_025167, Mlig455_046102, Mlig455_056419, Mlig455_063940 | Neo: - Age: - |
0.979 | - | - | - | - | 0.979 | - | Mlig455_014768 {REF} {Length: 115} {NoTransDecoderORF} {RNA1509_31462} {RNA1310_23820} {RNA815_18445} Mlig455_025167 {REF} {Length: 510} {NoTransDecoderORF} {RNA1509_32564} {RNA1310_77730} {RNA815_37446} Mlig455_046102 {REF} {Length: 325} {NoTransDecoderORF} {RNA1509_2515} {RNA1310_23566} {RNA815_3258.1} Mlig455_056419 {REF} {Length: 287} {NoTransDecoderORF} {RNA1509_46268} {RNA1310_13777} {RNA815_18445} Mlig455_063940 {REF} {Length: 3198} {RNA1509_31462} {RNA1310_56831} {RNA815_38594} |
|
| 20. | MligTC455_52318 | 64 | 1.34 | Mlig455_062030 | Neo: - Age: - Region-enriched R4: 4.894/0.00894 |
0.975 | - | - | 0.975 | - | - | - | Mlig455_062030 {REF} {Length: 1090} {RNA1509_6241} {RNA1310_26979} {RNA815_23904} | |
| 21. | MligTC455_04421 | 629 | 13.1 | Mlig455_008660, Mlig455_008671 | Neo: - Age: - Region-enriched R8: 2.627/0.01190 |
0.972 | - | - | - | - | - | 0.972 | Mlig455_008660 {REF} {Length: 2329} {Pfam: Major Facilitator Superfamily [PF07690.18, score=85.4]; MFS/sugar transport protein [PF13347.8, score=44.4]; MFS_1 like family [PF12832.9, score=35.8]; PUCC protein [PF03209.17, score=34.8]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [RH, Score=471, Expect=4e-162]} {RNA1509_18256} {RNA1310_12968} {RNA815_5192} Mlig455_008671 {REF} {Length: 2325} {Pfam: Major Facilitator Superfamily [PF07690.18, score=83.3]; MFS/sugar transport protein [PF13347.8, score=44.8]; MFS_1 like family [PF12832.9, score=35.3]; PUCC protein [PF03209.17, score=34.7]} {Smed: dd_Smed_v6_8550_0_1, dd_Smed_v6_8550_0_1, [RH, Score=468, Expect=1e-160]} {RNA1509_18256} {RNA1310_12968, RNA1509_18256} {RNA1509_18256, RNA815_5192} |
|
| 22. | MligTC455_19937 | 67 | 1.4 | Mlig455_048004 | Neo: - Age: Down-Up-Down Region-enriched R4: 5.334/0.01237 |
NKX2-2 | 0.972 | - | - | - | - | - | 0.972 | Mlig455_048004 {REF} {Length: 2666} {Pfam: Homeodomain [PF00046.31, score=72.6]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [Score=119, Expect=2e-31]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [Score=119, Expect=1e-31]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [Score=112, Expect=1e-27]} {Celegans: WBGene00000447, ceh-24, Homeobox protein ceh-24, [Score=95.5, Expect=9e-23]} {Smed: dd_Smed_v6_2716_0_3, dd_Smed_v6_2716_0_3, [Score=118, Expect=4e-30]} {RNA1509_27298} {RNA1310_16689.1} {RNA815_30453} |
| 23. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.971 | - | - | 0.971 | - | - | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
| 24. | MligTC455_47808 | 151 | 3.15 | Mlig455_066806 | Neo: - Age: - |
STAC2 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_066806 {REF} {Length: 4661} {Pfam: SH3 domain [PF00018.30, score=41.7]; Variant SH3 domain [PF14604.8, score=35.5]} {Human: ENSG00000141750, STAC2, SH3 and cysteine rich domain 2, [RH, Score=72.8, Expect=1e-12]} {Mouse: ENSMUSG00000017400, Stac2, SH3 and cysteine rich domain 2, [RH, Score=72.0, Expect=2e-12]} {Dmel: FBgn0263980, CG43729, [RH, Score=149, Expect=5e-36]} {Celegans: WBGene00006791, unc-57, Endophilin-A homolog, [Score=53.9, Expect=2e-08]} {Smed: dd_Smed_v6_14652_0_1, dd_Smed_v6_14652_0_1, [Score=172, Expect=1e-43]} {RNA1509_54523} {RNA1310_1618} {RNA815_6997} |
| 25. | MligTC455_15309 | 35 | 0.73 | Mlig455_065461, Mlig455_067184 | Neo: - Age: - |
FOXRED2 | 0.967 | - | - | - | - | - | 0.967 | Mlig455_065461 {REF} {Length: 2087} {Pfam: Pyridine nucleotide-disulphide oxidoreductase [PF13738.8, score=125.5]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=41.4]; L-lysine 6-monooxygenase (NADPH-requiring) [PF13434.8, score=35.0]; Pyridine nucleotide-disulphide oxidoreductase [PF00070.29, score=22.8]; FAD dependent oxidoreductase [PF01266.26, score=18.6]; HI0933-like protein [PF03486.16, score=18.6]} {Human: ENSG00000100350, FOXRED2, FAD dependent oxidoreductase domain containing 2, [Score=459, Expect=9e-154]} {Mouse: ENSMUSG00000016552, Foxred2, FAD-dependent oxidoreductase domain containing 2, [Score=457, Expect=2e-153]} {Smed: dd_Smed_v6_12138_0_1, dd_Smed_v6_12138_0_1, [RH, Score=464, Expect=5e-157]} {RNA1509_42325, RNA1509_58014} {RNA1310_12953, RNA1509_42325, RNA1509_58014} {RNA1509_42325, RNA1509_58014, RNA815_4760} Mlig455_067184 {REF} {Length: 2619} {Pfam: Pyridine nucleotide-disulphide oxidoreductase [PF13738.8, score=124.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=40.0]; L-lysine 6-monooxygenase (NADPH-requiring) [PF13434.8, score=36.5]; Pyridine nucleotide-disulphide oxidoreductase [PF00070.29, score=21.1]; FAD-NAD(P)-binding [PF13454.8, score=20.0]} {Human: ENSG00000100350, FOXRED2, FAD dependent oxidoreductase domain containing 2, [Score=460, Expect=1e-150]} {Mouse: ENSMUSG00000016552, Foxred2, FAD-dependent oxidoreductase domain containing 2, [Score=458, Expect=3e-150]} {Smed: dd_Smed_v6_12138_0_1, dd_Smed_v6_12138_0_1, [RH, Score=467, Expect=7e-155]} {RNA1509_42325} {RNA1310_12953} {RNA815_4760} |
| 26. | MligTC455_20900 | 185 | 3.85 | Mlig455_016663, Mlig455_056352, Mlig455_056364 | Neo: - Age: logFC(26M/2M)=0.440 Region-enriched R3: 6.081/0.00000 |
PTF1A | 0.967 | - | - | - | - | - | 0.967 | Mlig455_016663 {REF} {Length: 1779} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=69.4]} {Human: ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [RH, Score=114, Expect=2e-28]} {Mouse: ENSMUSG00000026735, Ptf1a, pancreas specific transcription factor, 1a, [RH, Score=112, Expect=5e-28]} {Dmel: FBgn0037475, Fer1, 48 related 1, [RH, Score=123, Expect=1e-32]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=86.7, Expect=2e-20]} {Smed: dd_Smed_v6_13704_0_1, dd_Smed_v6_13704_0_1, [RH, Score=126, Expect=2e-34]} {RNA1310_22164} {RNA815_43429} Mlig455_056352 {REF} {Length: 1831} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=69.3]} {Human: ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [RH, Score=114, Expect=3e-28]} {Mouse: ENSMUSG00000026735, Ptf1a, pancreas specific transcription factor, 1a, [RH, Score=112, Expect=6e-28]} {Dmel: FBgn0037475, Fer1, 48 related 1, [RH, Score=123, Expect=1e-32]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=86.7, Expect=2e-20]} {Smed: dd_Smed_v6_13704_0_1, dd_Smed_v6_13704_0_1, [RH, Score=126, Expect=3e-34]} {RNA1310_22164} {RNA815_43429} Mlig455_056364 {REF} {Length: 1756} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=69.3]} {Human: ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [RH, Score=114, Expect=3e-28]} {Mouse: ENSMUSG00000026735, Ptf1a, pancreas specific transcription factor, 1a, [RH, Score=112, Expect=5e-28]} {Dmel: FBgn0037475, Fer1, 48 related 1, [RH, Score=124, Expect=7e-33]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=86.7, Expect=2e-20]} {Smed: dd_Smed_v6_13704_0_1, dd_Smed_v6_13704_0_1, [RH, Score=126, Expect=3e-34]} {RNA1310_22164} {RNA815_43429} |
| 27. | MligTC455_51779 | 660 | 13.75 | Mlig455_031396 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.441/0.00016 |
CACNA1C | 0.967 | - | - | 0.967 | - | - | - | Mlig455_031396 {REF} {Length: 8157} {Pfam: Ion transport protein [PF00520.33, score=797.6]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=100.3]; Polycystin cation channel [PF08016.14, score=31.5]} {Human: ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1286, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1273, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1294, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=1288, Expect=0.0]; ENSMUSG00000031142, Cacna1f, calcium channel, voltage-dependent, alpha 1F subunit, [Score=1276, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1260, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1292, Expect=0.0]} {Celegans: WBGene00006742, unc-2, High voltage activated calcium channel alpha-1 subunit, [RH, Score=1690, Expect=0.0]} {Smed: dd_Smed_v6_13295_0_1, dd_Smed_v6_13295_0_1, [RH, Score=2129, Expect=0.0]} {RNA1509_11510} {RNA1310_2184.1} {RNA815_2606} |
| 28. | MligTC455_39663 | 257 | 5.36 | Mlig455_035826 | Neo: - Age: - Region-enriched R2: 2.079/0.03628 |
ERG | 0.965 | - | - | 0.965 | - | - | - | Mlig455_035826 {REF} {Length: 1844} {Pfam: Ets-domain [PF00178.24, score=118.3]} {Human: ENSG00000157554, ERG, ERG, ETS transcription factor, [RH, Score=206, Expect=1e-62]; ENSG00000151702, FLI1, Fli-1 proto-oncogene, ETS transcription factor, [RH, Score=200, Expect=1e-62]} {Mouse: ENSMUSG00000040732, Erg, ETS transcription factor, [RH, Score=204, Expect=2e-62]; ENSMUSG00000016087, Fli1, Friend leukemia integration 1, [RH, Score=200, Expect=2e-60]} {Dmel: FBgn0005658, Ets65A, Ets at 65A, [RH, Score=211, Expect=3e-67]} {Celegans: WBGene00020368, ast-1, Axon STeering defect, [RH, Score=185, Expect=5e-56]} {Smed: dd_Smed_v6_11113_0_1, dd_Smed_v6_11113_0_1, [RH, Score=237, Expect=2e-76]} {RNA1509_29423} {RNA1310_27275.1, RNA1509_29423} {RNA1509_29423, RNA815_13091} |
| 29. | MligTC455_13523 | 27 | 0.56 | Mlig455_068497 | Neo: - Age: - |
SBK1 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_068497 {REF} {Length: 1384} {Pfam: Protein kinase domain [PF00069.27, score=133.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.2]; Kinase-like [PF14531.8, score=18.7]} {Human: ENSG00000188322, SBK1, SH3 domain binding kinase 1, [Score=242, Expect=7e-76]} {Mouse: ENSMUSG00000042978, Sbk1, SH3-binding kinase 1, [Score=242, Expect=4e-76]} {Dmel: FBgn0034137, CG4945, [RH, Score=200, Expect=8e-59]} {Celegans: WBGene00009326, F32D8.1, [Score=109, Expect=6e-27]} {Smed: dd_Smed_v6_8041_0_1, dd_Smed_v6_8041_0_1, [Score=98.6, Expect=4e-23]} {RNA1310_104030} |
| 30. | MligTC455_23429 | 152 | 3.18 | Mlig455_032930, Mlig455_032945, Mlig455_041872 | Neo: - |
SEPT1, SEPT4 | 0.964 | - | - | - | 0.964 | - | - | Mlig455_032930 {REF} {Length: 2418} {Pfam: Septin [PF00735.20, score=155.7]; RsgA GTPase [PF03193.18, score=35.6]; AAA ATPase domain [PF13191.8, score=29.1]; 50S ribosome-binding GTPase [PF01926.25, score=26.5]; AAA domain [PF13401.8, score=19.4]; AIG1 family [PF04548.18, score=19.3]} {Human: ENSG00000180096, SEPT1, septin 1, [Score=146, Expect=2e-40]; ENSG00000122545, SEPT7, septin 7, [Score=144, Expect=2e-39]; ENSG00000108387, SEPT4, septin 4, [Score=142, Expect=3e-38]; ENSG00000184702, SEPT5, septin 5, [Score=142, Expect=9e-40]; ENSG00000168385, SEPT2, septin 2, [Score=141, Expect=2e-38]; ENSG00000284874, SEPT5-GP1BB, SEPT5-GP1BB readthrough, [Score=139, Expect=7e-38]} {Mouse: ENSMUSG00000000486, Sept1, septin 1, [Score=145, Expect=1e-40]; ENSMUSG00000001833, Sept7, septin 7, [Score=144, Expect=1e-39]; ENSMUSG00000026276, Sept2, septin 2, [Score=140, Expect=4e-40]; ENSMUSG00000020486, Sept4, septin 4, [Score=140, Expect=5e-38]; ENSMUSG00000116048, Sept2, septin 2, [Score=140, Expect=7e-39]; ENSMUSG00000116594, AC133488.1, novel protein, [Score=138, Expect=7e-38]; ENSMUSG00000072214, Sept5, septin 5, [Score=138, Expect=8e-38]} {Dmel: FBgn0011710, Sep1, Septin 1, [Score=140, Expect=9e-39]} {Celegans: WBGene00006793, unc-59, [Score=129, Expect=4e-34]} {Smed: dd_Smed_v6_4007_0_1, dd_Smed_v6_4007_0_1, [Score=150, Expect=3e-42]} {RNA1509_54075} {RNA1310_9163.1} {RNA815_3453} Mlig455_032945 {REF} {Length: 2512} {Pfam: Septin [PF00735.20, score=289.2]; RsgA GTPase [PF03193.18, score=33.4]; AAA ATPase domain [PF13191.8, score=28.5]; 50S ribosome-binding GTPase [PF01926.25, score=28.4]; AIG1 family [PF04548.18, score=18.3]} {Human: ENSG00000108387, SEPT4, septin 4, [Score=256, Expect=2e-78]; ENSG00000180096, SEPT1, septin 1, [Score=255, Expect=3e-79]; ENSG00000168385, SEPT2, septin 2, [Score=251, Expect=5e-78]; ENSG00000184702, SEPT5, septin 5, [Score=248, Expect=5e-77]; ENSG00000284874, SEPT5-GP1BB, SEPT5-GP1BB readthrough, [Score=248, Expect=8e-77]} {Mouse: ENSMUSG00000020486, Sept4, septin 4, [Score=254, Expect=3e-78]; ENSMUSG00000026276, Sept2, septin 2, [Score=251, Expect=2e-78]; ENSMUSG00000116048, Sept2, septin 2, [Score=251, Expect=2e-78]; ENSMUSG00000000486, Sept1, septin 1, [Score=250, Expect=8e-78]; ENSMUSG00000072214, Sept5, septin 5, [Score=246, Expect=2e-76]} {Dmel: FBgn0011710, Sep1, Septin 1, [Score=251, Expect=2e-78]} {Celegans: WBGene00006795, unc-61, [Score=216, Expect=3e-64]} {Smed: dd_Smed_v6_1717_0_1, dd_Smed_v6_1717_0_1, [Score=243, Expect=2e-74]} {RNA1509_54075} {RNA1310_9163.1} {RNA815_3453} Mlig455_041872 {REF} {Length: 2281} {Pfam: Septin [PF00735.20, score=289.1]; RsgA GTPase [PF03193.18, score=33.6]; AAA ATPase domain [PF13191.8, score=28.4]; 50S ribosome-binding GTPase [PF01926.25, score=28.3]; AIG1 family [PF04548.18, score=18.3]} {Human: ENSG00000108387, SEPT4, septin 4, [Score=256, Expect=2e-78]; ENSG00000180096, SEPT1, septin 1, [Score=255, Expect=3e-79]; ENSG00000168385, SEPT2, septin 2, [Score=250, Expect=6e-78]; ENSG00000284874, SEPT5-GP1BB, SEPT5-GP1BB readthrough, [Score=248, Expect=1e-76]; ENSG00000184702, SEPT5, septin 5, [Score=248, Expect=7e-77]} {Mouse: ENSMUSG00000020486, Sept4, septin 4, [Score=254, Expect=5e-78]; ENSMUSG00000116048, Sept2, septin 2, [Score=251, Expect=3e-78]; ENSMUSG00000026276, Sept2, septin 2, [Score=251, Expect=3e-78]; ENSMUSG00000000486, Sept1, septin 1, [Score=249, Expect=1e-77]; ENSMUSG00000072214, Sept5, septin 5, [Score=246, Expect=2e-76]} {Dmel: FBgn0011710, Sep1, Septin 1, [Score=249, Expect=6e-78]} {Celegans: WBGene00006795, unc-61, [Score=216, Expect=5e-64]} {Smed: dd_Smed_v6_1717_0_1, dd_Smed_v6_1717_0_1, [Score=243, Expect=2e-74]} {RNA1509_54075} {RNA1310_9163.1} {RNA815_3453} |
| 31. | MligTC455_23547 | 43 | 0.89 | Mlig455_025198 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_025198 {REF} {Length: 1912} {RNA1310_62305} {RNA815_43403} | |
| 32. | MligTC455_21034 | 1691 | 35.23 | Mlig455_010768 | Neo: - Age: - Region-specific R2: 2.955 Region-enriched R2: 1.870/0.00164 |
0.962 | - | - | - | - | - | 0.962 | Mlig455_010768 {REF} {Length: 608} {TRANSSPLICED} {RNA1509_10110} {RNA1310_54235.1, RNA1509_10110} {RNA1509_10110, RNA815_27381.1} | |
| 33. | MligTC455_34414 | 139 | 2.9 | Mlig455_044232, Mlig455_044249 | Neo: - Age: - |
C1GALT1 | 0.961 | - | - | 0.961 | - | - | - | Mlig455_044232 {REF} {Length: 1411} {Pfam: Fringe-like [PF02434.18, score=40.9]; Galactosyltransferase [PF01762.23, score=24.6]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=188, Expect=8e-57]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=184, Expect=2e-55]} {Dmel: FBgn0031468, CG2975, [Score=174, Expect=2e-51]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=194, Expect=4e-59]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=204, Expect=1e-63]} {RNA1310_37815} {RNA815_40424} Mlig455_044249 {REF} {Length: 1563} {Pfam: Fringe-like [PF02434.18, score=39.1]; Galactosyltransferase [PF01762.23, score=22.8]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=191, Expect=2e-55]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=185, Expect=1e-53]} {Dmel: FBgn0031468, CG2975, [Score=176, Expect=3e-50]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=206, Expect=1e-61]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=207, Expect=2e-62]} {RNA1310_37815} {RNA815_40424} |
| 34. | MligTC455_20897 | 308 | 6.42 | Mlig455_003823 | Neo: - Age: - |
RAC1 | 0.959 | - | - | 0.959 | - | - | - | Mlig455_003823 {REF} {Length: 1789} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=175.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=81.0]; ADP-ribosylation factor family [PF00025.23, score=31.4]} {Human: ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=277, Expect=1e-95]; ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=276, Expect=4e-95]; ENSG00000169750, RAC3, Rac family small GTPase 3, [Score=264, Expect=1e-90]} {Mouse: ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=277, Expect=9e-96]; ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=274, Expect=1e-94]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=264, Expect=1e-90]} {Dmel: FBgn0010333, Rac1, [Score=276, Expect=2e-95]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=269, Expect=5e-93]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=251, Expect=4e-86]} {RNA1509_26483} {RNA1310_15901, RNA1509_26483} {RNA1509_26483, RNA815_9219} |
| 35. | MligTC455_21467 | 816 | 17 | Mlig455_058500, Mlig455_058506 | Neo: - Age: Down-Up-Down Region-enriched R3: 4.231/0.00018 |
0.959 | - | - | - | - | - | 0.959 | Mlig455_058500 {REF} {Length: 466} {RNA1509_55725} {RNA1310_68398} {RNA815_42823} Mlig455_058506 {REF} {Length: 760} {RNA1509_55725} {RNA1310_68398, RNA1509_55725} {RNA1509_55725, RNA815_49141} |
|
| 36. | MligTC455_28280 | 163 | 3.4 | Mlig455_017596 | Neo: - Age: Up-Down-Down |
0.959 | - | - | - | - | 0.959 | - | Mlig455_017596 {REF} {Length: 6760} {tRNA: Val(CAC),pseudo, score=25.0} {RNA1509_40399} {RNA1310_340.1} {RNA815_1857} | |
| 37. | MligTC455_47755 | 718 | 14.95 | Mlig455_015222 | Neo: - Age: Down-Up-Down Region-specific R3: 5.936 Region-enriched R3: 5.432/0.00000 |
0.959 | - | - | - | - | - | 0.959 | Mlig455_015222 {REF} {Length: 799} {RNA1509_23394} {RNA1310_55274.1, RNA1509_23394} {RNA1509_23394, RNA815_31503.1} | |
| 38. | MligTC455_48063 | 63 | 1.31 | Mlig455_046268 | Neo: - Age: - Region-enriched R2: 5.256/0.00170 |
0.959 | - | - | 0.959 | - | - | - | Mlig455_046268 {REF} {Length: 749} {RNA1310_88363} {RNA815_47885} | |
| 39. | MligTC455_09312 | 275 | 5.72 | Mlig455_013317 | Neo: - Age: - |
NCOR1 | 0.958 | - | - | - | 0.958 | - | - | Mlig455_013317 {REF} {Length: 5104} {TRANSSPLICED} {Human: ENSG00000141027, NCOR1, nuclear receptor corepressor 1, [RH, Score=213, Expect=4e-55]; ENSG00000196498, NCOR2, nuclear receptor corepressor 2, [RH, Score=203, Expect=5e-52]} {Mouse: ENSMUSG00000018501, Ncor1, nuclear receptor co-repressor 1, [RH, Score=213, Expect=3e-55]} {Dmel: FBgn0265523, Smr, Smrter, [RH, Score=219, Expect=2e-57]} {Smed: dd_Smed_v6_7709_0_2, dd_Smed_v6_7709_0_2, [RH, Score=211, Expect=3e-55]} {RNA1509_5304} {RNA1310_3560} {RNA815_6348} |
| 40. | MligTC455_46341 | 243 | 5.06 | Mlig455_052880, Mlig455_052884 | Neo: - Age: - |
0.957 | - | - | 0.957 | - | - | - | Mlig455_052880 {REF} {Length: 1228} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=28.6]; Dpy-30 motif [PF05186.15, score=22.0]; Ankyrin repeats (many copies) [PF13637.8, score=20.9]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=60.5, Expect=6e-10]} {RNA1509_39973} {RNA1310_21889} {RNA815_13094} Mlig455_052884 {REF} {Length: 1926} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=39.4]; Ankyrin repeats (many copies) [PF13637.8, score=27.7]; Ankyrin repeats (many copies) [PF13857.8, score=24.6]; Dpy-30 motif [PF05186.15, score=21.6]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=72.8, Expect=1e-13]} {RNA1509_39973} {RNA1310_21889, RNA1509_39973} {RNA1509_39973, RNA815_13094} |
|
| 41. | MligTC455_27502 | 1437 | 29.93 | Mlig455_011453 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.324 Region-specific R2: 2.256 Region-enriched R2: 1.844/0.00000 |
GSTO1 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_011453 {REF} {Length: 2033} {TRANSSPLICED} {Pfam: Glutathione S-transferase, N-terminal domain [PF13417.8, score=70.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=60.2]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=41.9]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=27.3]; Glutathione S-transferase, C-terminal domain [PF16865.7, score=19.4]} {Human: ENSG00000148834, GSTO1, glutathione S-transferase omega 1, [RH, Score=120, Expect=2e-32]} {Mouse: ENSMUSG00000025068, Gsto1, glutathione S-transferase omega 1, [Score=120, Expect=6e-33]} {Dmel: FBgn0086348, se, sepia, [RH, Score=135, Expect=1e-38]} {Celegans: WBGene00001792, gst-44, Glutathione S-Transferase, [RH, Score=117, Expect=8e-32]} {Smed: dd_Smed_v6_10355_0_1, dd_Smed_v6_10355_0_1, [Score=94.4, Expect=3e-23]} {RNA1509_47286, RNA1509_59404, RNA1509_6588} {RNA1310_13251, RNA1509_47286, RNA1509_59404, RNA1509_6588} {RNA1509_47286, RNA1509_59404, RNA1509_6588, RNA815_4551.1} |
| 42. | MligTC455_27503 | 1438 | 29.97 | Mlig455_011534 | Neo: - Age: Up-Down-Down Region-specific R2: 2.218 Region-enriched R2: 1.795/0.00001 |
0.956 | - | - | - | 0.956 | - | - | Mlig455_011534 {REF} {Length: 464} {RNA1509_23020} {RNA1310_13251} {RNA815_4551.1} | |
| 43. | MligTC455_33753 | 508 | 10.58 | Mlig455_037018 | Neo: - Age: logFC(26M/2M)=-0.367 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_037018 {REF} {Length: 4215} {RNA1509_34999} {RNA1310_11373.3} {RNA815_18722.1} | |
| 44. | MligTC455_23850 | 1874 | 39.03 | Mlig455_013179 | Neo: - Age: logFC(26M/2M)=-0.484 |
TEKT3 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_013179 {REF} {Length: 3731} {TRANSSPLICED} {Pfam: Tektin family [PF03148.16, score=498.7]} {Human: ENSG00000125409, TEKT3, tektin 3, [RH, Score=488, Expect=2e-169]} {Mouse: ENSMUSG00000042189, Tekt3, tektin 3, [RH, Score=488, Expect=2e-169]} {Dmel: FBgn0052819, CG32819, [RH, Score=385, Expect=4e-129]} {Celegans: WBGene00019828, R02E12.4, [RH, Score=100, Expect=4e-22]} {Smed: dd_Smed_v6_3187_0_1, dd_Smed_v6_3187_0_1, [RH, Score=604, Expect=0.0]} {RNA1509_10506, RNA1509_14227, RNA1509_2063, RNA1509_35612} {RNA1310_11043, RNA1509_10506, RNA1509_14227, RNA1509_35612} {RNA1509_10506, RNA1509_14227, RNA1509_35612, RNA815_8448} |
| 45. | MligTC455_47152 | 7029 | 146.44 | Mlig455_034047, Mlig455_034073 | Neo: - Age: Down-Up-Up Region-specific R3: 6.221 Region-enriched R3: 5.965/0.00000 |
WSCD2 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_034047 {REF} {Length: 1396} {Pfam: WSC domain [PF01822.21, score=57.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=63.2, Expect=1e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=62.8, Expect=1e-10]} {RNA1509_26136, RNA1509_34383, RNA1509_46552, RNA1509_4725} {RNA1310_32158, RNA1509_26136, RNA1509_46552, RNA1509_4725} {RNA1509_26136, RNA1509_46552, RNA1509_4725, RNA815_15166} Mlig455_034073 {REF} {Length: 1503} {Pfam: WSC domain [PF01822.21, score=57.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=63.2, Expect=1e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=62.8, Expect=1e-10]} {RNA1509_30886, RNA1509_34383} {RNA1310_32158, RNA1509_30886, RNA1509_34383} {RNA1509_30886, RNA1509_34383, RNA815_15166} |
| 46. | MligTC455_04510 | 46 | 0.96 | Mlig455_027175 | Neo: - Age: Down-Up-Up |
C1GALT1 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_027175 {REF} {Length: 1524} {Pfam: Galactosyltransferase [PF01762.23, score=33.5]; Fringe-like [PF02434.18, score=32.7]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=162, Expect=2e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=164, Expect=1e-47]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=174, Expect=2e-51]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=180, Expect=1e-53]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=187, Expect=1e-56]} {RNA1509_52982} {RNA1310_22738.1} {RNA815_21441} |
| 47. | MligTC455_14447 | 1552 | 32.32 | Mlig455_044090 | Neo: - Age: Down-Up-Down |
0.954 | - | - | - | 0.954 | - | - | Mlig455_044090 {REF} {Length: 628} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4513) [PF14983.8, score=47.2]} {Smed: dd_Smed_v6_9820_0_1, dd_Smed_v6_9820_0_1, [RH, Score=92.8, Expect=2e-25]} {RNA1509_15130, RNA1509_30396} {RNA1310_35608, RNA1509_15130} {RNA1509_15130, RNA815_26600} | |
| 48. | MligTC455_43227 | 81 | 1.7 | Mlig455_040808, Mlig455_040907 | Neo: - Age: - |
0.954 | - | - | - | 0.954 | - | - | Mlig455_040808 {REF} {Length: 3396} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.5]} {RNA1310_94548} {RNA815_41738} Mlig455_040907 {REF} {Length: 3148} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.0]} {RNA1310_56531.1} {RNA815_41738} |
|
| 49. | MligTC455_05720 | 156 | 3.26 | Mlig455_040120 | Neo: - Age: - |
CHRNB3 | 0.953 | - | - | 0.953 | - | - | - | Mlig455_040120 {REF} {Length: 1839} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=90.2]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=205, Expect=1e-59]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=204, Expect=4e-59]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=197, Expect=3e-56]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=197, Expect=3e-56]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=196, Expect=7e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=206, Expect=5e-60]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=201, Expect=5e-58]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=197, Expect=4e-57]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=204, Expect=3e-59]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=201, Expect=5e-58]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=364, Expect=8e-120]} {RNA1310_53963} {RNA815_48325} |
| 50. | MligTC455_15324 | 212 | 4.42 | Mlig455_018628 | Neo: - Age: - |
CAPN7 | 0.953 | - | - | - | 0.953 | - | - | Mlig455_018628 {REF} {Length: 2837} {TRANSSPLICED} {Pfam: Calpain family cysteine protease [PF00648.23, score=151.6]; Calpain large subunit, domain III [PF01067.24, score=65.5]; MIT (microtubule interacting and transport) domain [PF04212.20, score=58.0]} {Human: ENSG00000131375, CAPN7, calpain 7, [RH, Score=818, Expect=0.0]} {Mouse: ENSMUSG00000021893, Capn7, calpain 7, [RH, Score=830, Expect=0.0]} {Dmel: FBgn0003464, sol, small optic lobes, [Score=121, Expect=1e-27]} {Celegans: WBGene00000543, clp-2, CaLPain family, [RH, Score=621, Expect=0.0]} {Smed: dd_Smed_v6_6402_0_1, dd_Smed_v6_6402_0_1, [RH, Score=812, Expect=0.0]} {RNA1509_9441} {RNA1310_7284} {RNA815_5790} |
| 51. | MligTC455_20990 | 179 | 3.72 | Mlig455_022232 | Neo: - Age: logFC(26M/2M)=6.763 Region-enriched R3: 7.994/0.00000 |
MEP1B | 0.953 | - | - | - | - | - | 0.953 | Mlig455_022232 {REF} {Length: 921} {Pfam: Astacin (Peptidase family M12A) [PF01400.26, score=158.6]} {Human: ENSG00000141434, MEP1B, meprin A subunit beta, [RH, Score=130, Expect=1e-33]} {Mouse: ENSMUSG00000024313, Mep1b, meprin 1 beta, [RH, Score=132, Expect=1e-34]} {Dmel: FBgn0039069, CG6763, [RH, Score=147, Expect=3e-42]} {Celegans: WBGene00003525, nas-6, Zinc metalloproteinase nas-6, [RH, Score=143, Expect=8e-41]} {Smed: dd_Smed_v6_85_0_1, dd_Smed_v6_85_0_1, [RH, Score=131, Expect=3e-37]} {RNA1509_2621} {RNA1310_42790.1} {RNA815_21158.1} |
| 52. | MligTC455_20991 | 187 | 3.89 | Mlig455_022250 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=6.428 Region-enriched R3: 6.761/0.00001 |
MEP1B | 0.953 | - | - | - | - | - | 0.953 | Mlig455_022250 {REF} {Length: 892} {Pfam: Astacin (Peptidase family M12A) [PF01400.26, score=158.6]} {Human: ENSG00000141434, MEP1B, meprin A subunit beta, [RH, Score=130, Expect=1e-33]} {Mouse: ENSMUSG00000024313, Mep1b, meprin 1 beta, [RH, Score=132, Expect=1e-34]} {Dmel: FBgn0039069, CG6763, [RH, Score=147, Expect=3e-42]} {Celegans: WBGene00003525, nas-6, Zinc metalloproteinase nas-6, [RH, Score=143, Expect=8e-41]} {Smed: dd_Smed_v6_85_0_1, dd_Smed_v6_85_0_1, [RH, Score=131, Expect=3e-37]} {RNA1509_2621} {RNA1310_42790.1} {RNA815_21158.1} |
| 53. | MligTC455_33936 | 62 | 1.29 | Mlig455_061181 | Neo: - Age: Down-Down-Up Region-enriched R3: 4.766/0.00000 |
0.953 | - | - | - | - | - | 0.953 | Mlig455_061181 {REF} {Length: 2443} {Pfam: Fibronectin type II domain [PF00040.21, score=54.5]} {Mouse: ENSMUSG00000054580, Pla2r1, phospholipase A2 receptor 1, [Score=50.1, Expect=2e-06]} {RNA1310_23349.1} {RNA815_44226.1} | |
| 54. | MligTC455_27659 | 84 | 1.74 | Mlig455_018407 | Neo: - Age: - |
0.952 | - | - | 0.952 | - | - | - | Mlig455_018407 {REF} {Length: 1746} {NoTransDecoderORF} {RNA1509_40699} {RNA1310_17673.2} {RNA815_24644.1} | |
| 55. | MligTC455_33080 | 814 | 16.95 | Mlig455_049373 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.494 Region-specific R3: 6.455 Region-enriched R3: 6.051/0.00000 |
FN1 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_049373 {REF} {Length: 1253} {Pfam: Fibronectin type II domain [PF00040.21, score=92.6]; Calcium-binding EGF domain [PF07645.17, score=30.5]} {Human: ENSG00000115414, FN1, fibronectin 1, [RH, Score=83.6, Expect=7e-18]} {Mouse: ENSMUSG00000026193, Fn1, fibronectin 1, [RH, Score=85.5, Expect=1e-18]} {Celegans: WBGene00007170, B0393.5, [Score=51.2, Expect=2e-07]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [Score=52.0, Expect=5e-08]} {RNA1509_35441, RNA1509_9115} {RNA1310_32646.1, RNA1509_35441, RNA1509_9115} {RNA1509_35441, RNA1509_9115, RNA815_14924.1} |
| 56. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
| 57. | MligTC455_35734 | 1207 | 25.15 | Mlig455_016267 | Neo: - Age: - |
PBX1 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_016267 {REF} {Length: 2584} {TRANSSPLICED} {Pfam: PBC domain [PF03792.15, score=246.8]; Homeodomain [PF00046.31, score=70.3]; Homeobox KN domain [PF05920.13, score=55.9]} {Human: ENSG00000185630, PBX1, PBX homeobox 1, [RH, Score=398, Expect=2e-139]; ENSG00000167081, PBX3, PBX homeobox 3, [RH, Score=395, Expect=9e-137]} {Mouse: ENSMUSG00000052534, Pbx1, pre B cell leukemia homeobox 1, [RH, Score=398, Expect=2e-139]; ENSMUSG00000038718, Pbx3, pre B cell leukemia homeobox 3, [RH, Score=395, Expect=5e-137]} {Dmel: FBgn0000611, exd, extradenticle, [RH, Score=401, Expect=3e-140]} {Celegans: WBGene00000443, ceh-20, Homeobox protein ceh-20, [RH, Score=355, Expect=1e-122]} {Smed: dd_Smed_v6_3098_0_1, dd_Smed_v6_3098_0_1, [RH, Score=370, Expect=6e-128]} {RNA1509_47841, RNA1509_52495, RNA1509_8058} {RNA1310_11055, RNA1509_47841, RNA1509_52495, RNA1509_8058} {RNA1509_47841, RNA1509_52495, RNA1509_8058, RNA815_18271} |
| 58. | MligTC455_38018 | 3083 | 64.24 | Mlig455_045082 | Neo: - Age: Up-Down-Down Region-specific R3: 6.880 Region-enriched R3: 6.761/0.00000 |
HMCN1 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_045082 {REF} {Length: 16670} {Pfam: Galactose binding lectin domain [PF02140.20, score=169.4]; von Willebrand factor type A domain [PF13519.8, score=37.4]; von Willebrand factor type A domain [PF00092.30, score=29.5]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=103, Expect=5e-21]; ENSG00000148357, HMCN2, hemicentin 2, [Score=102, Expect=9e-21]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=103, Expect=4e-21]} {Dmel: FBgn0033313, Cirl, Calcium-independent receptor for alpha-latrotoxin, [RH, Score=73.2, Expect=4e-12]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=85.1, Expect=6e-16]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=97.4, Expect=9e-20]} {RNA1509_18605, RNA1509_262} {RNA1310_79.1, RNA1509_18605} {RNA1509_18605, RNA815_38} |
| 59. | MligTC455_40614 | 25 | 0.52 | Mlig455_030882 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_030882 {REF} {Length: 1647} {RNA1509_37399} {RNA1310_18527} {RNA815_9560} |